Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Therapeutic Advances in Chronic Disease
|
January 16, 2016
A review of the medical treatment of primary sclerosing cholangitis in the 21st century
Elizabeth C Goode, Simon M Rushbrook
Therapeutic Advances in Chronic Disease
|
July 3, 2013
Therapeutic advances in the management of chronic hepatitis B infection
Johanne Brooks, William Gelson, Simon M Rushbrook
Gastroenterology
|
May 5, 2016
An Unexpected Cause of Pancreatitis
Khoon-Sheng Kok, Richard Wharton, Simon M Rushbrook
Hepatology (Baltimore, Md.)
|
September 25, 2019
Reply
Elizabeth C Goode, Gideon M Hirschfield, Simon M Rushbrook
Expert Opinion on Biological Therapy
|
October 27, 2007
T-regulatory lymphocytes and chronic viral hepatitis
Simon M Rushbrook, Matthew Hoare, Graeme J M Alexander
Gastroenterology
|
April 30, 2013
A rare cause of cholangiopathy
Elizabeth C Goode, Benedict W Simpson, Simon M Rushbrook
Postgraduate Medical Journal
|
June 16, 2010
Endoscopic ultrasound: a review of current diagnostic and therapeutic applications
Edmund M Godfrey, Simon M Rushbrook, Nicholas R Carroll, et al.
Frontiers in Immunology
|
February 21, 2022
The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease
John P Thomas, Dezso Modos, Simon M Rushbrook, et al.
Biomed Research International
|
November 14, 2013
Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis
Chun Shing Kwok, Lukasz Krupa, Ash Mahtani, et al.
Journal of Virology
|
May 28, 2005
Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection
Simon M Rushbrook, Scott M Ward, Esther Unitt, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Therapeutic Advances in Chronic Disease
|
January 16, 2016
A review of the medical treatment of primary sclerosing cholangitis in the 21st century
Elizabeth C Goode, Simon M Rushbrook
Therapeutic Advances in Chronic Disease
|
July 3, 2013
Therapeutic advances in the management of chronic hepatitis B infection
Johanne Brooks, William Gelson, Simon M Rushbrook
Gastroenterology
|
May 5, 2016
An Unexpected Cause of Pancreatitis
Khoon-Sheng Kok, Richard Wharton, Simon M Rushbrook
Hepatology (Baltimore, Md.)
|
September 25, 2019
Reply
Elizabeth C Goode, Gideon M Hirschfield, Simon M Rushbrook
Expert Opinion on Biological Therapy
|
October 27, 2007
T-regulatory lymphocytes and chronic viral hepatitis
Simon M Rushbrook, Matthew Hoare, Graeme J M Alexander
Gastroenterology
|
April 30, 2013
A rare cause of cholangiopathy
Elizabeth C Goode, Benedict W Simpson, Simon M Rushbrook
Postgraduate Medical Journal
|
June 16, 2010
Endoscopic ultrasound: a review of current diagnostic and therapeutic applications
Edmund M Godfrey, Simon M Rushbrook, Nicholas R Carroll, et al.
Frontiers in Immunology
|
February 21, 2022
The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease
John P Thomas, Dezso Modos, Simon M Rushbrook, et al.
Biomed Research International
|
November 14, 2013
Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis
Chun Shing Kwok, Lukasz Krupa, Ash Mahtani, et al.
Journal of Virology
|
May 28, 2005
Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection
Simon M Rushbrook, Scott M Ward, Esther Unitt, et al.
Page
of 3